Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
Colorectal cancer (CRC) is the second leading cause of cancer death in the world.Immunotherapy using monoclonal Fragrance Set antibodies, immune-checkpoint inhibitors, adoptive cell therapy, and cancer vaccines has raised great hopes for treating poor prognosis metastatic CRCs that are resistant to the conventional therapies.However, high inter-tum